Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 107.70M P/E - EPS this Y -4.80% Ern Qtrly Grth -
Income -66.7M Forward P/E -2.11 EPS next Y 6.70% 50D Avg Chg -28.00%
Sales 689k PEG - EPS past 5Y - 200D Avg Chg -42.00%
Dividend N/A Price/Book 2.76 EPS next 5Y - 52W High Chg -71.00%
Recommedations 1.70 Quick Ratio 2.73 Shares Outstanding 45.90M 52W Low Chg 6.00%
Insider Own 17.98% ROA -63.92% Shares Float 29.66M Beta -0.19
Inst Own 20.49% ROE -179.67% Shares Shorted/Prior 3.50M/2.88M Price 3.40
Gross Margin -159.94% Profit Margin - Avg. Volume 497,835 Target Price 12.00
Oper. Margin -4,338.36% Earnings Date Jun 20 Volume 556,749 Change -2.02%
About Beyond Air, Inc.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Beyond Air, Inc. News
03/20/24 Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
02/12/24 Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024
01/18/24 Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
12/27/23 Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors
12/23/23 Beyond Air Independent Director Acquires 102% More Stock
12/21/23 Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc
11/15/23 Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference
11/13/23 Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024
11/03/23 Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
10/19/23 Beyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast
10/17/23 Beyond Air® To Participate in the Truist Securities BioPharma Symposium
10/17/23 Beyond Cancer™ Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice
10/16/23 Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10/16/23 Beyond Air® Receives Innovative Technology Contract from Vizient for LungFit®PH
10/04/23 Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10/02/23 Beyond Air® To Participate in the Roth MKM 2023 Healthcare Opportunities Conference
09/27/23 Beyond Cancer™ to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual Meeting
09/18/23 Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder
09/15/23 Beyond Air Insiders Placed Bullish Bets Worth US$2.3m
09/07/23 Beyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region
XAIR Chatroom

User Image Ernst_Grafenberg Posted - 11 hours ago

@rnchor @rkatz @VernCapital all I know is that this company has been a massive failure. Complete shareholder destruction. I'm blaming Lisi for over promising and consistently under delivering. $XAIR

User Image rkatz Posted - 17 hours ago

$XAIR This board is useless. I'm a long but I bash the stock calling management names lol. Why would you not just sell the stock? Only a Moron would hold a stock if you did not believe in management. Oh you are short or want people to sell to you because you know good things are about to happen.

User Image rkatz Posted - 18 hours ago

$XAIR Let me guess your uncle got eaten by cannibals too? Just keep making stuff up Goofyberg

User Image BlueCollarDollars Posted - 18 hours ago

$XAIR

User Image rkatz Posted - 18 hours ago

$XAIR The real scam is you!

User Image Ernst_Grafenberg Posted - 18 hours ago

$TTOO $XAIR $TDOC don't forget to complete the loser's survey. The winning CEO will get a direct note congratulating them for their ability to completely and utterly wipe out investor savings. https://twitter.com/ErnstGMan/status/1782816457639731505?t=y7HH4gFNncL-gUBIywuFDg&s=19

User Image rkatz Posted - 18 hours ago

$XAIR Prove it! Post the return EMail or STFU!

User Image Ernst_Grafenberg Posted - 22 hours ago

@PumpinFE this is a trash stpck. I emailed XAIR investor relations a couple of days ago and Lisi responded directly (not the first time it's happened). It was such a dejected response. He just talked about things not going as they expected but they'd continue working to help patients. $XAIR

User Image PumpinFE Posted - 22 hours ago

$XAIR Anyone notice how much Gendell Jeffrey L has purchased? This information can be found on Marketbeat. Anyway, this individual has made massive buys since 2021....11/21, 11/22, 5/23, 8/23, 11/23. Anyway, no idea if there is a connection but Jeffrey Gendell is managing member of Tontine Assets Associations and they also have significant stake in Avadel Pharmaceuticals (4.9% ownership)....same company that Steve Lisi was former Vice President. While there as Vice President, Lisi was instrumental in restructuring the company, raising over 125m and transforming it from a 100m enterprise value to 1B in 3 years.

User Image Ernst_Grafenberg Posted - 23 hours ago

$XAIR turnaround today or sub $1?

User Image Dknght Posted - 1 day ago

$XAIR Up 7-cents after hours AND 600k volume today(mostly buys). Clearly, selling is done and accumulation is happening(again). Last week, there was a 600k volume day of mostly selling. So, it appears that(for the 3rd time in as many months), this is on rinse and repeat between $1.15 and $1.65. Obviously, someone is manipulating this(and making A LOT of money doing so...33% profit per cycle).

User Image Ernst_Grafenberg Posted - 1 day ago

$XAIR once a trash stock, always a trash stock

User Image Say_Whaaaat Posted - 1 day ago

$XAIR insiders are on blackout until earnings call aren't they? That's not for 2 months yet

User Image VernCapital Posted - 1 day ago

$XAIR looks like the ask got caught on the hop there up to 1.60. Already squeezed it back down. That was a 36% move in 2 mins

User Image VernCapital Posted - 1 day ago

$XAIR i smell another insider move

User Image VernCapital Posted - 1 day ago

$XAIR that was 117k candle

User Image Ernst_Grafenberg Posted - 1 day ago

$XAIR massive volume. Carey loading up

User Image Sporked Posted - 1 day ago

$XAIR what was that

User Image slevin_kelevra Posted - 1 day ago

$XAIR It appers Robert Carey bought again

User Image Ernst_Grafenberg Posted - 1 day ago

$XAIR nope, still trash

User Image Ernst_Grafenberg Posted - 1 day ago

$XAIR turnaround this week?1

User Image TimMccain Posted - 3 days ago

$XAIR someone please tell me something market doesn't know about this

User Image BlueCollarDollars Posted - 4 days ago

$XAIR https://x.com/tradethematrix1/status/1781274948897530012?s=46 IWM and XBI correlation is strong, applies both ways. Sector bleed will continue until rate cuts and inflation actually lightens. This is bigger and scarier than a possible Lisi/CE problem. That being said, I do believe we see an uptick in Rev + Contracts come June ER followed by positive cancer dataset in July. How much that will spike the stock beats me. Yes there is 16mil in dilution but the company has time to distribute all that and I don’t think they will do it significantly here at ATLs. Weekend food for thought.

User Image Say_Whaaaat Posted - 4 days ago

$XAIR $XFOR best move I could have made

User Image Ernst_Grafenberg Posted - 4 days ago

$XAIR is that color green? It can't be

User Image bee_water Posted - 4 days ago

$XAIR The only way to revive the stock price in the near term is strong revenue. Don't think BC data will help anymore. @ Steve Lisi and co if you are listening

User Image JohnnyAceParisi Posted - 4 days ago

$XAIR I’m still here, just nothing to say

User Image VernCapital Posted - 4 days ago

$XAIR relax - sell off market as getting in “sell in May and go away’ early - interest rate cuts push back not good for small caps. XBI dropped off the back - SPY taking a breather after decent run.

User Image Ernst_Grafenberg Posted - 5 days ago

@Cris76 $XAIR has potential but incompetent leadership. Cancer data? Who cares, the company will go under before there's any progress made. The filters work but some other company will buy the rights to them at rock bottom prices. Dilution near all time lows, delays, lies from management. The list goes on. So pissed at myself for getting looped into this fraud.

User Image Ernst_Grafenberg Posted - 5 days ago

$XAIR Def sub $1 tomorrow if markets crash. Israel-Iran are in the brink.

Analyst Ratings
Truist Securities Buy Nov 14, 23
Piper Sandler Overweight Jul 28, 23
Truist Securities Buy Jul 21, 23
Oppenheimer Outperform Jun 23, 23
BTIG Buy Jun 15, 23
Truist Securities Buy Jun 29, 22
Ladenburg Thalmann Buy Jun 29, 22
Truist Securities Buy Nov 12, 21
Truist Securities Buy Apr 28, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Carey Robert Director Director Dec 18 Buy 1.635 1,200,000 1,962,000 2,374,454 12/19/23
Carey Robert Director Director Aug 18 Buy 2.7 88,664 239,393 975,160 08/22/23
Carey Robert Director Director Mar 29 Buy 6.38 20,000 127,600 886,496 03/30/23
Lee Yoori Director Director Mar 28 Buy 6.34 3,115 19,749 12,654 03/29/23
Carey Robert Director Director Nov 16 Buy 5.9 50,000 295,000 792,323 11/18/22
Gaul Michael A. Chief Operating Offi.. Chief Operating Officer Aug 22 Buy 9.42 2,000 18,840 64,150 08/22/22
Carey Robert Director Director Mar 24 Buy 6.62 26,185 173,345 547,323 03/28/22
Lisi Steven A. CEO and Chairman of.. CEO and Chairman of the Board Jan 12 Option 3.66 83,334 305,002 1,233,445 01/14/22
BENTSUR RON Director Director Nov 24 Sell 13.72 37,464 514,006 182,436 11/26/21